Previous issues
- Page Path
-
- HOME
- BROWSE ARTICLES
- Previous issue
|
- Reviews
- Current understanding of primary biliary cholangitis
- Atsushi Tanaka
- Clin Mol Hepatol. 2021;27(1):1-21. Published online December 3, 2020
- The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
- Erica Jennison, Christopher D. Byrne
- Clin Mol Hepatol. 2021;27(1):22-43. Published online December 10, 2020
- Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
- Gwyneth Soon, Aileen Wee
- Clin Mol Hepatol. 2021;27(1):44-57. Published online November 19, 2020
- Recent updates on the management of autoimmune hepatitis
- Atsumasa Komori
- Clin Mol Hepatol. 2021;27(1):58-69. Published online December 10, 2020
- The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
- Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
- Clin Mol Hepatol. 2021;27(1):70-80. Published online December 3, 2020
- Editorials
- Drug-drug interactions with direct-acting antivirals — less is more
- Grace Lai-Hung Wong
- Clin Mol Hepatol. 2021;27(1):81-82. Published online December 3, 2020
- Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
- Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
- Clin Mol Hepatol. 2021;27(1):83-86. Published online December 3, 2020
- Metabolic disease as a risk of hepatocellular carcinoma
- Naoshi Nishida
- Clin Mol Hepatol. 2021;27(1):87-90. Published online December 3, 2020
- The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?
- Beom Kyung Kim
- Clin Mol Hepatol. 2021;27(1):91-93. Published online December 3, 2020
- Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
- Marta Tonon, Salvatore Piano
- Clin Mol Hepatol. 2021;27(1):94-96. Published online December 3, 2020
- Elimination of hepatitis C: What would be the practical approach?
- Hyung Joon Yim
- Clin Mol Hepatol. 2021;27(1):97-99. Published online December 3, 2020
- Outcomes of Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir in Mongolian Population: Successes and Challenges Facing Scale-up of Care
- Seong Hee Kang, Moon Young Kim
- Clin Mol Hepatol. 2021;27(1):100-102. Published online December 3, 2020
- Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma
- Jun Won Kim, Ik Jae Lee
- Clin Mol Hepatol. 2021;27(1):103-106. Published online December 14, 2020
- Old hepatitis B virus never dies: It just hides itself within the host genome
- Jeong-Hoon Lee
- Clin Mol Hepatol. 2021;27(1):107-109. Published online December 23, 2020
- Original Articles
- Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
- Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
- Clin Mol Hepatol. 2021;27(1):110-124. Published online December 3, 2020
- Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
- Oidov Baatarkhuu, Jae Seung Lee, Jazag Amarsanaa, Do Young Kim, Sang Hoon Ahn, Nyamsuren Naranzul, Damba Enkhtuya, Nagir Choijamts, Purev Batbayar, Radnaa Otgonbayar, Bat-Ulzii Saruul, Chuluunbaatar Gantuul, Baljinnyam Gegeebadrakh, Narangerel Tuvshinbayar, Dorjgotov Badamsuren, Galsan Ulzmaa, Jamiyandorj Otgonbold, Kwang-Hyub Han
- Clin Mol Hepatol. 2021;27(1):125-135. Published online November 27, 2020
- Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
- Chung-Feng Huang, Pey-Fang Wu, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Cheng-Ting Hsu, Po-Yao Hsu, Hung-Yin Liu, Ying-Chou Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
- Clin Mol Hepatol. 2021;27(1):136-143. Published online December 3, 2020
- Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study
- Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park
- Clin Mol Hepatol. 2021;27(1):144-156. Published online December 7, 2020
- Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
- Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon
- Clin Mol Hepatol. 2021;27(1):157-174. Published online November 26, 2020
- Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients
- Priyanka Jain, Saggere Muralikrishna Shasthry, Ashok Kumar Choudhury, Rakhi Maiwall, Guresh Kumar, Ankit Bharadwaj, Vinod Arora, Rajan Vijayaraghavan, Ankur Jindal, Manoj Kumar Sharma, Vikram Bhatia, Shiv Kumar Sarin
- Clin Mol Hepatol. 2021;27(1):175-185. Published online December 3, 2020
- Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
- Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Wan-Long Chuang, Chung-Feng Huang, Yi-Wen Chiu, Ming-Lung Yu
- Clin Mol Hepatol. 2021;27(1):186-196. Published online December 3, 2020
- The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
- Se Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, Soung Won Jeong, Moon Young Kim, Young Kyu Cho, Young Chang, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Soon Koo Baik, Yong Jae Kim, Su Yeon Park, Baigal Baymbajav
- Clin Mol Hepatol. 2021;27(1):197-206. Published online December 3, 2020
- Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
- Jeong Won Jang, Jin Seoub Kim, Hye Seon Kim, Kwon Yong Tak, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Lewis R. Roberts
- Clin Mol Hepatol. 2021;27(1):207-218. Published online December 3, 2020
- Letter to the Editor
- A dilemma that probably would never resolve
- Ravi Thanage, Shubham Jain, Sanjay Chandnani, Pravin Rathi
- Clin Mol Hepatol. 2021;27(1):219-220. Published online December 3, 2020
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
